Rapport Therapeutics (NASDAQ:RAPP) Is In A Strong Position To Grow Its Business

Simply Wall StDec 9 22:09

Jefferies Maintains Rapport Therapeutics(RAPP.US) With Buy Rating, Maintains Target Price $35

Futu NewsDec 9 21:31 · Ratings

Rapport Therapeutics, Inc. (RAPP) Receives a Buy From Jefferies

TipRanksDec 9 21:26 · Ratings

We're Not Worried About Rapport Therapeutics' (NASDAQ:RAPP) Cash Burn

Yahoo FinanceDec 7 20:18

Rapport Therapeutics Reports Correlation Between Seizure Biomarker, Clinical Seizures

MT NewswiresDec 7 01:36

Express News | Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in Rns Measured Long Episodes and Meaningful Reductions in Clinical Seizures

BreakingsDec 7 01:01